The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...
A far shorter, simpler, and less toxic treatment protocol for patients with triple-negative breast cancer produced outcomes ...
The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel ...
WHTM Harrisburg on MSN7h
Pennsylvania Breast Cancer Coalition awards $200,000 in grantsThe Pennsylvania Breast Cancer Coalition presented grants to two local researchers. Each received $100,000 for their work at ...
Patients diagnosed with more advanced breast cancer are more likely to have cardiovascular disease, a large study suggests.
A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...
A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ...
Katrina Cooke and Ashley Dostefano share their personal journeys, reflecting on the challenges they faced, the victories they ...
Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...
According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...
Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in ...
Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated positive overall survival results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback